Tisheng Bio

Tisheng Bio (瑅盛生物) is a Chinese biotech startup founded by Li Yi (李懿) and backed by FreeS Fund (峰瑞资本), which lists it among its portfolio companies alongside 迦进生物, 安然菲医药, 至简生物, and Shennong; Li Yi and FreeS managing partner Shen Jiong have appeared together at FreeS-organized healthcare events, including a March 2025 biomedical innovation summit in Suzhou and a September 2025 session on AI in healthcare .

Beyond that, elsewhere's corpus does not cover the company in depth — there's no material here on its specific therapeutic focus, pipeline, or financing history, so a fuller profile isn't something I can source.